These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6644321

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM, Ho KC.
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [Abstract] [Full Text] [Related]

  • 23. [1st trials of a new contrast medium, iopamidol, in the study of the spinal canal].
    Bories J, Chiras J, Drouineau J.
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):789-92. PubMed ID: 6670841
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Iopamidol (B 15000), a nonionic water-soluble contrast medium for neuroradiology. Part I: Results of a clinical trial for myelography.
    Bacarini L, de Nicola T, Gasparini D, Orlando P, Vassallo A.
    Neuroradiology; 1982 Dec; 23(2):81-4. PubMed ID: 7043305
    [No Abstract] [Full Text] [Related]

  • 27. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F, van Dongen K, Hekster R, Hoogland P, Thijssen H, Tjian T, Wilmink J, Althuisius H.
    Diagn Imaging; 1983 Dec; 52(6):313-5. PubMed ID: 6357678
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Iopamidol for myelography--practical implications.
    de Villiers PD, Snyman PJ, van Rensburg MN, Lamprecht DS, Greeff GP.
    S Afr Med J; 1984 Nov 03; 66(18):697-8. PubMed ID: 6495113
    [Abstract] [Full Text] [Related]

  • 30. Iopamidol vs metrizamide: a double blind study for cervical myelography.
    Drayer BP, Warner MA, Sudilovsky A, Luther J, Wilkins R, Allen S, Bates M.
    Neuroradiology; 1982 Nov 03; 24(2):77-84. PubMed ID: 7177374
    [Abstract] [Full Text] [Related]

  • 31. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.
    Sovak M, Ranganathan R, Kerber CW, Bickford R, Alksne JF.
    AJNR Am J Neuroradiol; 1983 Nov 03; 4(3):319-22. PubMed ID: 6410733
    [Abstract] [Full Text] [Related]

  • 32. The prophylactic use of phenytoin during iopamidol contrast studies of the subarachnoid space.
    de Vane PJ, Macpherson P, Teasdale E, Volo G, Casey M, Kelly JC, Whiting B.
    Eur J Clin Pharmacol; 1986 Nov 03; 29(6):747-9. PubMed ID: 3709621
    [Abstract] [Full Text] [Related]

  • 33. [Myelography and headache].
    Hammer B.
    Wien Med Wochenschr; 1985 Jun 15; 135(11):259-63. PubMed ID: 3895752
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F, Ciccarelli R, Cirillo S, D'Auria T, Gambardella A, La Tessa G, Meoli S, Rotondo A, Santoro S.
    Radiol Med; 1980 Apr 15; 66(4):203-10. PubMed ID: 7005985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM, Ho KC.
    Radiology; 1980 Aug 15; 136(2):395-7. PubMed ID: 6773100
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.